Modulators of orphan nuclear receptors for NASH and other metabolic disorders
US12318393B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Inventors
Key dates
| Filing date | May 3, 2019 |
| Grant date | Jun 3, 2025 |
| Priority date | — |
| Expiry date | Jun 19, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods for modulating retinoic acid receptor-like orphan receptors (ROR) and associated diseases. Methods for treatment or prophylaxis of metabolic disorders, liver disorders or diseases, including NASH, immune disorders, central nervous system disorders, or cancer are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.